Lung disease in obese patients with sleep apnea
Part of Lungs & breathing clinical trials.
This study looks at whether obesity and sleep apnea together cause lung damage. It uses CT scans of the lungs to check for changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be obese, with a body mass index (BMI) of 30 or higher.
- You must have been diagnosed with obstructive sleep apnea (OSA) using a sleep study.
- You need to have had a high-resolution CT scan of your lungs that is available for the study doctors to review.
- You cannot have had lung surgery or a lung transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying how a treatment may work for adults who have interstitial lung disease or obstructive sleep apnea. It likely involves sleep testing so the team can measure breathing and sleep patterns.
This study looks at the link between fatty liver disease and obstructive sleep apnea. It may help understand if one condition affects the other.
This study will check if obese people who use a CPAP machine for sleep apnea also have trouble breathing during the night. We want to see how common this problem is and find ways to help.
This study looks at how repeated episodes of low oxygen during sleep affect the body in people with severe sleep apnea. It may help researchers understand what causes symptoms and long-term risks, which could guide better treatment decisions.
This study looks at how body fat (“adipose tissue”) may differ in people with obstructive sleep apnea. You may be asked for consent and could be asked to stop certain medicines short-term so researchers can take a safe fat sample.
This study looks at how lung scarring affects oxygen levels during sleep and exercise. It may help find better ways to monitor and treat breathing problems in people with fibrotic interstitial lung disease.
Hear when a new ILD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.